In total, we characterized CD4 and CD8 T cells from 52 patient samples, including 30 PB and 22 BM samples, from 21 patients, which included PB-BM pairs and longitudinal samples, constituting a substantial resource for T-cell functional in AML. This evidence concerns the gene CD4 and acute myeloid leukemia.